Vokes EE - Search Results

1

Differential expression of RON in small and non-small cell lung cancers.

Kanteti R, Krishnaswamy S, Catenacci D, Tan YH, EL-Hashani E, Cervantes G, Husain AN, Tretiakova M, Vokes EE, Huet H, Salgia R. Kanteti R, et al. Among authors: vokes ee. Genes Chromosomes Cancer. 2012 Sep;51(9):841-51. doi: 10.1002/gcc.21968. Epub 2012 May 14. Genes Chromosomes Cancer. 2012. PMID: 22585712

2

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.

Hoffman PC, Cohen EE, Masters GA, Haraf DJ, Mauer AM, Rudin CM, Krauss SA, Huo D, Vokes EE. Hoffman PC, et al. Among authors: vokes ee. Lung Cancer. 2002 Oct;38(1):65-71. doi: 10.1016/s0169-5002(02)00144-7. Lung Cancer. 2002. PMID: 12367795 Clinical Trial.

3

A phase II study of bryostatin-1 and paclitaxel in patients with advanced non-small cell lung cancer.

Winegarden JD, Mauer AM, Gajewski TF, Hoffman PC, Krauss S, Rudin CM, Vokes EE. Winegarden JD, et al. Among authors: vokes ee. Lung Cancer. 2003 Feb;39(2):191-6. doi: 10.1016/s0169-5002(02)00447-6. Lung Cancer. 2003. PMID: 12581572 Clinical Trial.

4

Targeted therapies for stage III non-small cell lung cancer: integration in the combined modality setting.

Vokes EE, Choy H. Vokes EE, et al. Lung Cancer. 2003 Aug;41 Suppl 1:S115-21. doi: 10.1016/s0169-5002(03)00155-7. Lung Cancer. 2003. PMID: 12867070 Review.

5

Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.

Cohen EE, Vokes EE. Cohen EE, et al. Among authors: vokes ee. Hematol Oncol Clin North Am. 2004 Feb;18(1):81-90. doi: 10.1016/s0889-8588(03)00148-5. Hematol Oncol Clin North Am. 2004. PMID: 15005282 Review.

6

Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.

Socinski MA, Zhang C, Herndon JE 2nd, Dillman RO, Clamon G, Vokes E, Akerley W, Crawford J, Perry MC, Seagren SL, Green MR. Socinski MA, et al. Ann Oncol. 2004 Jul;15(7):1033-41. doi: 10.1093/annonc/mdh282. Ann Oncol. 2004. PMID: 15205196 Free article.

7

Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.

Mehta N, Mauer AM, Hellman S, Haraf DJ, Cohen EE, Vokes EE, Weichselbaum RR. Mehta N, et al. Among authors: vokes ee. Int J Oncol. 2004 Dec;25(6):1677-83. Int J Oncol. 2004. PMID: 15547705 Clinical Trial.

8

Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer.

Vokes EE, Crawford J, Bogart J, Socinski MA, Clamon G, Green MR. Vokes EE, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5045s-5050s. doi: 10.1158/1078-0432.CCR-05-9008. Clin Cancer Res. 2005. PMID: 16000612 Review.

9

Adjuvant and neoadjuvant therapy for early-stage non-small-cell lung cancer.

Choong NW, Vokes EE. Choong NW, et al. Among authors: vokes ee. Clin Lung Cancer. 2005 Dec;7 Suppl 3:S98-104. doi: 10.3816/clc.2005.s.018. Clin Lung Cancer. 2005. PMID: 16384544 Review.

10

A phase I study of pemetrexed, carboplatin, and concurrent radiotherapy in patients with locally advanced or metastatic non-small cell lung or esophageal cancer.

Seiwert TY, Connell PP, Mauer AM, Hoffman PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ, Vokes EE. Seiwert TY, et al. Among authors: vokes ee. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):515-22. doi: 10.1158/1078-0432.CCR-06-1058. Clin Cancer Res. 2007. PMID: 17255273 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

559 results

Search Page